Mitoxantrone Hydrochloride
규격
70476-82-3CAS 번호
274-619-1EC 번호
1,4-dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione;dihydrochlorideIUPAC 명칭
C22H30Cl2N4O6화학식
517.4 g/mol분자량
70476-82-3; Mitoxantrone hydrochloride; Mitoxantrone dihydrochloride; CL-232315; Onkotrone; DTXSID0045173; Mitozantrone hydrochloride; CL 232,315; U6USW86RD0; NSC-301739; CL 232315; DTXCID8025173; CHEBI:50727; 1,4-Dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)anthraquinone dihydrochloride; 9,10-Anthracenedione, 1,4-dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)-, dihydrochloride; 1,4-Dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]anthraquinone dihydrochloride; NSC301739; Mitroxone; Neotalem; Pralifan; RefChem:55657; Mitoxantroni Hydrochloridum; Hydrochloride, Mitoxantrone; Dihydroxyanthracenedione Dihydrochloride; 1,3-Dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)-9, 10-anthracenedione Dihydrochloride; 1,4-Dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)-9, 10-anthroquinone Dihydrochloride; 274-619-1; Mitoxantrone HCl; Novantrone; Novantron; Mitoxantrone 2HCl; Mitoxantrone Dihcl; 1,4-Dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)anthracene-9,10-dione dihydrochloride; Mitoxantrone (dihydrochloride); MITOXANTHRONE HYDROCHLORIDE; DHAD; MFCD00242943; mitozantrone dihydrochloride; 1,4-dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione;dihydrochloride; 1,4-Dihydroxy-5,8-bis-[2-(2-hydroxyethylamino)ethylamino]anthraquinone dihydrochloride; Immunex; 9,10-Anthracenedione,1,4-dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-, dihydrochloride; Bisantrone; mitoxanthrone hcl; CCRIS 2592; HSDB 6543; NCGC00015693-02; EINECS 274-619-1; CAS-70476-82-3; UNII-U6USW86RD0; NSC 301739; Eslep; SR-01000076001; Novantron (TN); 1,4-dihydroxy-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)anthracene-9,10-dione dihydrochloride; Mitoxantrone hydrochloride; 1,4-Dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]anthracene-9,10-dione dihydrochloride; Prestwick_571; 1,4-dihydroxy-5,8-bis-[2-(2-hydroxyethylamino)ethylamino]anthraquinone 2hcl; 1,4-dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione hydrochloride; Mitoxantrone hydrochloride [USAN:USP:JAN]; 70476-82-3 (HCl); Mitoxantron dihydrochloride; SCHEMBL3928; orb134620; Mitoxantrone hydrochloride CRS; SPECTRUM1503278; NSC 301739 dihydrochloride; orb1224183; orb1310885; CHEMBL1417019; SCHEMBL29366412; SCHEMBL29462659; GLXC-03046; HMS1569M11; HMS1922O21; HMS5081E11; HY-13502AR; dhaq dihydrochloride 65271-80-9; Tox21_110197; Tox21_500779; CCG-39938; EBC-00689; HY-13502A; s2485; Mitoxantrone hydrochloride (JAN/USP); AKOS015895228; Tox21_110197_1; AC-1591; FM61451; LP00779; MITOXANTRONE HYDROCHLORIDE [JAN]; MITOXANTRONE DIHYDROCHLORIDE [MI]; MITOXANTRONE HYDROCHLORIDE [HSDB]; MITOXANTRONE HYDROCHLORIDE [USAN]; NCGC00015693-09; NCGC00094116-01; NCGC00094116-02; NCGC00094116-03; NCGC00094116-04; NCGC00261464-01; AS-13162; Mitoxantrone (dihydrochloride) (Standard); MITOXANTRONE HYDROCHLORIDE [MART.]; MITOXANTRONE HYDROCHLORIDE [VANDF]; Mitoxantrone Hydrochloride - API Standards; MITOXANTRONE HYDROCHLORIDE [USP-RS]; MITOXANTRONE HYDROCHLORIDE [WHO-DD]; DB-055419; EU-0100779; M3110; M3379; Mitoxantrone Dihydrochloride (NSC 301739); NS00091303; SW196745-5; Mitoxantrone dihydrochloride, >=97% (HPLC); D02166; EN300-268139; M 6545; MITOXANTRONE HYDROCHLORIDE [EP IMPURITY]; MITOXANTRONE HYDROCHLORIDE [ORANGE BOOK]; MITOXANTRONE HYDROCHLORIDE [EP MONOGRAPH]; F036509; MITOXANTRONE HYDROCHLORIDE [USP MONOGRAPH]; SR-01000076001-1; SR-01000076001-8; Q27122209; Z2569867923; Mitoxantrone hydrochloride, European Pharmacopoeia (EP) Reference Standard; 1,4-dihydroxy-5,8-bis-[[2-(2-hydroxyethylamino)ethyl]amino]-anthraquinone dihydrochloride; 1,4-dihydroxy-5,8-bis-[2-(2-hydroxyethylamino)ethylamino]anthraquinonedihydrochloride; 1,4-dihydroxy-5,8-bis[[2-(2-hydroxyethylamino)ethyl]amino]anthraquinone dihydrochloride; Mitoxantrone hydrochloride, United States Pharmacopeia (USP) Reference Standard; 1,4-dihydroxy-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)-9,10-dihydroanthracene-9,10-dione dihydrochloride; 1,4-Dihydroxy-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)anthracene-9,10-dione--hydrogen chloride (1/2)동의어
Mitoxantrone Hydrochloride 함유 제품
미트론주(미톡산트론염산염)ノバントロン注20mgノバントロン注10mgMITOXANTRONA ACCORD 2 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFGMITOXANTRONE ACCORD 2 mg/mL, solution à diluer pour perfusionMitoxantron "Ebewe"Mitoxantrone HClMitoxantrone HydrochlorideMITOXANTRONE DIHYDROCHLORIDEMitoxantrone HydrochlorideMitoxantrone HCl
Mitoxantrone Hydrochloride 판매 기업
YX
YANTAI XIANHUA TECHNOLOGY GROUP CO.,LTDChinaWH
Wuxi Hexia Chemical CompanyChinaAH
Accord Healthcare S.L.U.Spain이연
이연제약(주)Republic of Koreaあす
あすか製薬株式会社JapanSH
Shenzhen Haorui Pharmatech Co., Ltd.ChinaSC
Shanghai Chematis Co., Ltd.ChinaAC
AFINE CHEMICALS LIMITED